Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
4.925
-0.315 (-6.01%)
Jan 13, 2026, 3:54 PM EST - Market open
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $263.92 million as of January 13, 2026. Its market cap has increased by 6.33% in one year.
Market Cap
263.92M
Enterprise Value
136.89M
1-Year Change
6.33%
Ranking
Category
Stock Price
$4.93
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $263.92M, an increase of 52.41%. That is a compound annual growth rate of 7.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 280.80M | -1.69% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 972.73B |
| Johnson & Johnson | 512.82B |
| AbbVie | 387.30B |
| UnitedHealth Group | 305.13B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 269.82B |
| Novo Nordisk | 263.26B |